|
|
|
|
|
|
Biomatrik Inc. is a leading supplier of highly pure, monodispersed polyethylene glycol (PEG) products with various repeating units n (spacer length), end functional groups (X and Y) and various molecular architecture (linear, branched, and multi-armed).
PEGs has earned their place in the biomedical field due to their water solubility, non-toxicity, and non-immunogenicity properties. To date, there are 12 pegylated drugs approved by the FDA to treat a number of chronic diseases.
While most PEG products are a mixture of different molecular weights, Biomatrik supplies monodispersed, single molecular weight molecules. Through our innovative technology, we have the ability to manufacture pure and monodispersed PEGs with precise molecular weights. Biomatrik developed the first acid functionalized PEG that is used to conjugate antibody and toxin (ADC drug) that will be launched commercially to treat breast cancer.
PEG’s impact on biological therapies has increased the number of suppliers and manufacturers, but none have come close to our quality. Biomatrik stands as the world leader in PEG research and development. |
|
|
| polyethylene glycol, PEG, PEG derivative, 聚乙二醇衍生物, Mal, HS, NH2, OH, N3, 试剂 |
|
|
| Company : |
Biomatrik Inc. |
| Email: |
Contact us |
| URL: |
********
|
| Phone: |
*********
|
| Fax : |
*********
|
| Country : |
China |
| Address : |
*********
|
|
|
|
|
|
